Author(s):
A. Lakshmi Usha, M. Kusama Kumari, E. Radha Rani, M. Ramadevi
Email(s):
alakshmiusha@gmail.com
DOI:
10.52711/2231-5659.2021-11-2-7
Address:
A. Lakshmi Usha*, M. Kusama Kumari1, E. Radha Rani1, M. Ramadevi
Department of Pharmaceutics, Maharajah’s College of Pharmacy, Vizianagaram, A.P., India.
*Corresponding Author
Published In:
Volume - 11,
Issue - 2,
Year - 2021
ABSTRACT:
The barrier properties of the topmost layer of the skin, stratum corneum have significant limitations for successful systemic delivery of a wide range of therapeutic molecules, especially macromolecules and genetic material. One solution is to utilize microneedles (MNs), which are capable of painlessly traversing through the stratum corneum and directly translocating protein drugs into the systematic circulation. This strategy involves the use of micron sized needles fabricated from different materials and using different geometries to create transient aqueous conduits across the skin. Microneedles in isolation, or in combination with other enhancing strategies, have been shown to dramatically enhance the skin permeability of numerous therapeutic molecules including biopharmaceuticals either in vitro, ex vivo or in vivo. MNs can be designed to incorporate appropriate structural materials as well as therapeutics or formulations with tailored physicochemical properties. This platform technique has been applied to deliver drugs both locally and systemically in applications ranging from vaccination to diabetes and cancer therap. As an alternative to hypodermic needles, coated polymer microneedles (MNs) are able to deliver drugs to subcutaneous tissues after being inserted into the skin. The dip-coating process is a versatile, rapid fabricating method that can form coated MNs in a short time. However, it is still a challenge to fabricate coated MNs with homogeneous and precise drug doses in the dip-coating process. This review article focuses on recent and potential future developments in microneedle technologies. This will include the detailing of progress made in microneedle design, an exploration of the challenges faced in this field and potential forward strategies to embrace the exploitation of microneedle methodologies, while considering the inherent safety aspects of such therapeutic tools. The clinical potential and future translation of MNs are also discussed.
Cite this article:
A. Lakshmi Usha, M. Kusama Kumari, E. Radha Rani, M. Ramadevi. A Novel Technique for Intradermal Delivery of Drugs – Coated Polymeric Needles. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(2):133-9. doi: 10.52711/2231-5659.2021-11-2-7
Cite(Electronic):
A. Lakshmi Usha, M. Kusama Kumari, E. Radha Rani, M. Ramadevi. A Novel Technique for Intradermal Delivery of Drugs – Coated Polymeric Needles. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(2):133-9. doi: 10.52711/2231-5659.2021-11-2-7 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2021-11-2-7
REFERENCES:
1. Aoyagi S, Izumi H, Fukuda M. Biodegradable polymer needle with various tip angles and consideration on insertion mechanism of mosquito’s proboscis. Sensors and Actuators A: Physical. 2008;143(1): 20–28.
2. Aoyagi S, Izumi H, Isono Y, et al. Laser fabrication of high aspect ratio thin holes on biodegradable polymer and its application to a microneedle. Sensors and Actuators A: Physical. 2007; 139(1-2): 293–302.
3. Bal SM, Ding Z, Kersten GF, et al. Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphteria toxoid formulations. Pharmaceutical Research. 2010;27(9): 1837–1847.
4. Bal SM, Caussin J, Pavel S, et al. In vivo assessment of safety of microneedle arrays in human skin. European Journal of Pharmaceutical Sciences. 2008; 35(3):193–202.
5. Banga AK. Therapeutic Peptides and Proteins: Formulation, Processing and Delivery Systems. CRC Press Taylor and Francis Group; Boca Raton: 2006.
6. Banga AK. Microporation applications for enhancing drug delivery. Expert Opinion on Drug Delivery. 2009;6(4): 343–354.
7. Birchall JC, Clemo R, Anstey A, et al. Microneedles in clinical practice - an exploratory study into the opinions of healthcare professionals and the public. Pharmaceutical Research. 2011; 28(1): 95–106.
8. Saurabh Tiwari, Shweta Singh, Pushpendra Kumar Tripathi, Chetan Kumar DubeyTransdermal Drug Therapy- A Novel Approach for Acne Vulgaris Treatment, Research Journal of Topical and Cosmetic Sciences, 2016; 7(1): 23-26
9. Boehm RD, Miller PR, Singh R, et al. Indirect rapid prototyping of antibacterial acid anhydride copolymer microneedles. Biofabrication. 2012; 4(1): 011002.
10. Brunner M, Derendorf H. Clinical microdialysis: Current applications and potential use in drug development. Trends in Analytical Chemistry. 2006; 25(7): 674–680.
11. Bystrova S, Luttge R. Micromolding for ceramic microneedle arrays. Microelectronic Engineering. 2011;88(8): 1681–1684.
12. Chabri F, Bouris K, Jones T, et al. Microfabricated silicon microneedles for nonviral cutaneous gene delivery. British Journal of Dermatology. 2004;150(5): 869–877.
13. Chandrasekaran S, Brazzle JD, Frazier AB. Surface micromachined metallic microneedles. Journal of Microelectromechanical Systems. 2003; 12(3): 281–288.
14. Kalmath K. V., Swamy H. K. S., Inamdar S. S.. Polymeric Transdermal Drug Delivery Films of Iso-Sorbide Dinitrate. Research J. Pharm. and Tech.3 (4): Oct.-Dec.2010; Page 1175-1177
15. Lhernould, M.S.; Deleers, M.; Delchambre, A. Hollow polymer microneedles array resistance and insertion tests. Int. J. Pharm. 2015, 480, 152–157.
16. R.B. Saudagar, S. Samuel. Ethosomes: Novel noninvasive carrier for Transdermal Drug Delivery. Asian J. Pharm. Tech. 2016; 6(2): 135-138
17. Kanchan R. Pagar, Sarika V. Khandbahale. A Review on Novel Drug Delivery System: A Recent Trend. Asian J. Pharm. Tech. 2019; 9(2): 135-140.
18. Jepps, O.G.; Dancik, Y.; Anissimov, Y.G.; Roberts, M.S. Modeling the human skin barrier— Towards a better understanding of dermal absorption. Adv. Drug Deliv. Rev. 2013, 65, 152–168.
19. Flaten, G.E.; Palac, Z.; Engesland, A.; Filipović-Grčić, J.; Vanić, Ž.; Škalko-Basnet, N. In vitro skin models as a tool in optimization of drug formulation. Eur. J. Pharm. Sci. 2015, 75, 10–24.
20. Olatunji, O.; Das, D.B.; Garland, M.J.; Belaid, L.; Donnelly, R.F. Influence of array interspacing on the force required for successful microneedle skin penetration: Theoretical and practical approaches. J. Pharm. Sci. 2013, 102, 1209–1221.
21. Cheung, K.; Han, T.; Das, D.B. Effect of Force of Microneedle Insertion on the Permeability of Insulin in Skin. J. Diabetes Sci. Technol. 2014, 8, 444–452.
22. Kaur, M.; Ita, K.B.; Popova, I.E.; Parikh, S.J.; Bair, D.A. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate. Eur. J. Pharm. Biopharm. 2014, 86, 284–291.
23. Coulman S, Allender C, Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Critical Reviews in Therapeutic Drug Carrier Systems. 2006a; 23(3): 205–258.
24. Coulman SA, Barrow D, Anstey A, et al. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Current Drug Delivery. 2006b; 3 (1): 65–75.
25. Manvir Aujla, A.C. Rana, Rajni Bala, Nimrata Seth. Comparative Potential of Vesicular Carriers for Transdermal Drug Delivery: A Review. Research J. Pharm. and Tech. 5(3): Mar.2012; Page 302-306.
26. Sweta S. Solanki, Karan B. Patel, Jalpa G. Patel, Manish P. Patel, Jayvadan K. Patel. Transdermal Drug Delivery Systems: A Review. Research J. Pharm. and Tech. 5(6): June 2012; Page 757-763.
27. Davis SP, Martanto W, Allen MG, et al. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans. Biomed. Eng. 2005; 52(5): 909–915.
28. Davis SP, Landis BJ, Adams ZH, et al. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. Journal of Biomechanics. 2004; 37(8): 1155–1163.
29. Ding Z, Verbaan FJ, Bivas-Benita M, et al. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. Journal of Controlled Release. 2009; 136(1): 71–78.
30. Donnelly RF,, Garland MJ, Morrow DI, et al. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. Journal of Controlled Release. 2010; 147(3): 333–341.
31. Umekar MJ, Biyani DM, Amgaonkar YM, Bhoyar PK, Lade UB, Kalsait RP. Formulation Development and Evaluation of Transdermal Drug Delivery System of Antihypertensive Drug. Research J. Pharm. and Tech.3 (3): July-Sept. 2010; Page 753-757.
32. Dinesh Mishra, Anuja Mishra, Vaibhav Dubey, Karunakar Shukla. Transdermal Immunization: A Recent Tool for Immnization. Research J. Pharm. and Tech.3 (4): Oct.-Dec.2010; Page 964-969.
33. Rajashri R.Kulkarni, Dipti G.Phadtare.The Microneedle Patches: An Innovative Approach. Asian J.Pharma Tech. 2015; Vol.5(4): 195-200
34. Vidyasagar Patidar, Dinesh Sharma, Deepika Maliwal, Vivekanand Chatap. Penetration Enhancement Techniques for Transdermal Drug Delivery System. Research J. Pharm. and Tech. 2(1): Jan.-Mar. 2009; Page 28-33.